Spergualin (Ia) is an antitumor antibiotic that was discovered in culture filtrates of Bacillus laterosporus BMG162-aF2, and has been determined to be (-)-(15S)-1-amino-l9-guanidino-11,15-dihydroxy-4,9,12-triazanonadecane-10,13-dione. ',2) Its total synthesis has also been accomplished;
acid-catalyzed condensation of 11-amino-1,1-dihydroxy-3,8-diazaundecan-2-one [a hydrate of glyoxylylspermidine] (II) with (S)-7-guanidino-3-hydroxyheptanamide (IIIa) followed by separation from the 11-epimeric mixture gives spergualin. 3) We applied this condensation reaction to analogue synthesis. Our first effort was directed to the modification of the 7-guanidino-3-hydroxyacyl moiety because of its versatile functional property.
In addition, we synthesized the 11-O-alkyl-derivatives, because they were expected to be stable. We then examined their antitumor activity against mouse leukemia L-1210. In this paper, we report on the preparation of the spergualin analogues and derivatives described above, and present the results of the structure-activity studies.
Chemistry

Acid-catalyzed Condensation Reaction
A number of analogues were synthesized by acid-catalyzed condensation of w-guanidinoalkanamides (the amide component III) with glyoxylylspermidine (the aldehyde component II), as shown in Scheme 1. Primary amides can be added to aldehydes in the presence of acids or bases to give Nacylated aminoalcohols,4) which correspond to the N-acylated-l-hydroxyglycine moiety of spergualin.
During the study of chemical synthesis of spergualin it was necessary to examine various conditions of the condensation reaction including catalysts and solvents, because reactive functional groups such as guanidino or amino groups were present in both components. These two reactive groups were pro- A mixture of 7-guanidinoheptanamide • HCI (IX, 0.17 mmol), glyoxylylspermidine • 2HCI (II, 0.17 mmol) and respective acid in 1120 (5 mg) was heated at 60°C for 15 hours.
The yield of condensed product (18) was estimated by HPLC using Nucleosil 5C18 column, 9 % acetonitrile -0.005 M Na pentansulfonate -0.01 M Na2HPO4 (pH 3) as the developing solvent and Na o-aminobenzoate as the internal standard.
tected by protonation.
Further we studied the effects of different catalysts.
The results are summarized in Table 1 . (S)-7-Guanidino-3-hydroxyheptanamide (IIIa), which was obtained by acid hydrolysis of spergualin (Ia), was used as a starting material. Acylation of the hydroxyl group of Illa by acid anhydrides or acid chlorides with pyridine gave the corresponding (S)-3-acyloxy-7-guanidinoheptanamides (V).
Racemic w-guanidino-3-hydroxyalkanamides other thanIIIa were synthesized from the corresponding N-protected w-amino-3-keto-fatty acid esters (VIIIc). N-Protected w-amino-fatty acids (VIIIa) were converted into reactive imidazolides (VIIIb) and were condensed with magnesium enolate of monoethyl malonate (XIII) to give 3-keto-esters (VIIIc), in which two-carbons units were increased.5) Reduction of the carbonyl group with NaBH4, ammonolysis of the ester group with ammonium hydroxide, and removal of the amino protective group gave w-amino-3-hydroxyalkanamides (1IIb). Conversion of the regenerated amino group with S-methylisothiourea into a guanidino group gave the desired wguanidino-3-hydroxyalkanamides (IIIc).
(o-Guanidino-2-alkenamides (VI) were prepared by dehydration of IIIa, c with dicyclohexylcarbodiimide (DCC) and cupric chloride II.°' w-Guanidinoalkanamides (IX) were synthesized from the corresponding w-amino-fatty acids (VII). Treatment of (v-amino-fatty acids (VII) with S-methylisothiourea in alkaline solution gave w-guanidino-fatty acids (VIIIe). Conversion of the carboxyl group into methyl ester (VIIIf) and ammonolysis with ammonium hydroxide gave w-guanidinoalkanamides (IX).
w-Guanidino-2-hydroxyalkanamides (XII) were synthesized by either of two methods from aamino acids such as L-arginine or L-lysine (X), or from a cyanohydrin intermediate (XId) . In the first method, conversion of a-amino group into a-hydroxyl group with nitrous acid and the successive transformation of carboxylic acid into amide, and (o-amino group into w-guanidino group in the case of L-lysine, gave the desired compounds (XII). In the second method, racemic compound (XII) was synthesized via the cyanohydrin intermediate (XId); reduction of N-protected a)-amino-fatty acid imidazolide (VIIIb) with LiAIH4 gave the corresponding aldehyde (VIIId); the aldehyde (VIIId) was converted to cyanohydrin (Xld) with hydrogen cyanide. Removal of the N-protecting group of Xld and hydration of cyano group with 35% hydrogen chloride gave w-amino-2-hydroxyalkanamide (XIb). Conversion of the (o-amino group into a guanidino group gave the desired amide (XII). All of these w-guanidinoalkanamides were prepared as their hydrochlorides, and employed in the acid-catalyzed condensation with glyoxylylspermidine (II).
Preparation of Glyoxylylspermidine
Glyoxylylspermidine (I1) was obtained by acid hydrolysis of natural spergualin (Ia), as shown in Scheme 1. The chemical synthesis of II has been accomplished by UMEZAWA et al.3) Recently, we have devised a facile method that can be applied for preparation of II and its analogues. This method will be reported in another paper.
Preparation of 11-O-Alkyl-derivatives
Acid-catalyzed reaction of various alcohols with the condensation products described above or spergualin readily gave 11-O-alkylated derivatives. An advantage of 11-O-alkylation is that these derivatives are more stable than the original compound in aqueous solution.
All analogues and derivatives thus prepared were mixtures of epimers in 11-C. Effective methods for preparing optically active analogues and II-O-alkylated derivatives will be reported elsewhere. Table 2 . 15-O-Propionyl 4 and n-butyryl 6 derivatives had satisfactory activity. Acylation of the hydroxyl group with long-chain fatty acids decreased the activity (compounds 7, 8, 9, 10, 11 and 12) .
15-Benzoyl derivative 13 had little activity. These results suggested that if the hydrophilic portion becomes hydrophobic or a sterically bulky group is attached to the 15-hydroxyl group, the activity decreases.
In addition, the 15-hydroxyl group may not be essential for the activity. The following Results are shown as life prolongation (T/C %) in this Table and Tables 3 and 4 . Table 3 . Antitumor activity of 15-deoxyspergualin analogues and their 11-O-alkyl-derivatives.
H2NCNH ( showed that this group was, in fact, unnecessary.
We prepared analogues in which the 7-guanidino-3-hydroxyheptanamide (IIIa) of spergualin was displaced by w-guanidinoalkanamide comprising 4 to 9 carbon atoms. The structures and their antitumor activities are given in The chain length of the w-guanidino-acyl residue was important for activity, and this was also true in other analogues having a hydroxyl or double-bond in the w-guanidinoalkan amide moiety, as for compounds 27, 28, 31 and 34 (Table 4) .
It was also interesting that 14-hydroxyl analogue 29 was inactive, although its carbon-chain length was sufficient for activity.
The w-guanidino group was essential for activity, as shown by the results for compound 36.
11-O-Alkylated compounds 5, 19, 20, 21, 22 and 26 had less activity than the corresponding 11-hydroxyl compounds.
In conclusion, among the spergualin analogues and derivatives so far tested, 15-deoxvspergualin 18 and its homolog 25 had strong activity, superior to that of spergualin.
Experimental
MP were determined using a Yanagimoto melting point apparatus, and are uncorrected. None of the analogues or derivatives of spergualin in this report had a definite mp. 1R spectra were taken on a Hitachi EPI-G2 or 273-30 spectrophotometer.
NMR spectra were determined with a Hitachi R-24B (60 MHz) spectrometer. High performance liquid chromatography (HPLC) was done using a system consisting of an Altex 100A pump, Shimadzu CTO-2A column oven, Soma S-310A UV detector, and Shimadzu C-RIB Chromatopac recorder.
(A) Preparation of 15-O-Acylspergualins (Compounds 3-13) (15S)-15-Acetoxy-1-amino-19-guanidino-l1-hvdroxy-4,9.12-triazanonadecane-10,13-dione (15-0-Ac _etylspergualin 3) To 813 mg (3.41 mmol) of (S)-7-guanidino-3-hydroxyheptanamide (IIIa) (HC1 salt) were added 7 ml of pyridine and 7 ml of acetic anhydride. The mixture was stirred at room temp overnight. The reaction mixture was poured into 100 nil of H2O, concentrated under reduced pressure, and chromatographed on a CM-Sephadex C-25 (Na+) column (450 ml) with linear gradient elution using H2O (1.5 liters) and I M NaCl solution (1.5 liters). The fractions containing the desired product were collected and evaporated to dryness, and the residue was extracted with MeOH. The MeOH extract was passed through a Sephadex LH-20 column (1.5 liters), and then eluted with MeOH. The fractions positive for the Sakaguchi reaction were combined and evaporated to dryness, giving 753 mg (78.8//,) of (S)-7-guanidino-3-acetoxyheptanamide (HCl salt) as a syrup: IR (KBr) 3330, 3160, 2930, 2850, 1720, 1660, 1425, 1370, 1255, 1175, 1025 A procedure similar to that used for compound 3 was followed in the preparation of the 15-0-acylspergualins. To purify the intermediate and final products, chromatography on Diaion HP-20 was used as well as CM-Sephadex C-25 (Na+) and Sephadex LH-20. For acylation of IIIa, propionic anhydride, isobutyric anhydride, n-valeric anhydride, n-hexanoic anhydride, n-octanoic anhydride, n-decanoic anhydride, n-tetradecanoic anhydride, or benzyl chloride was used with pyridine and N,Ndimethylformamide.
Spectral data of the final products numbered from 4 to 13 were as follows. [a]D = 3. (15S)-1-Amino-l5-decanoyloxy-l9-guanidino-11-hydroxy-4,9,12-triazanonadecane-10,13-dione (15-0-Decanoylspergualin 11)
[a]D --3.3-(c 1, H,O); IR (KBr) 3340, 3160, 2950, 2920, 2850, 1730, 1650, 1525, 1460, 1370, 1245, 1160, 1105, 1070 collected by filtration and washed with cold water and acetone to give 7-guanidinoheptanoic acid as crude crystals. The crystals were dissolved in 36 ml of 2 N HCl with heat and left at room temp overnight, giving 11.0 g (84%) of 7-guanidinoheptanoic acid (HCl salt) as white crystals: mp 166-167.5°C; IR (KBr) 3400, 3250, 3170, 3100, 2930, 2850, 1720, 1675, 1635, 1605, 1470, 1410, 1395, 1225, 1170 , 800, 790 cm-1; 1H NMR (D2O) 1.2-1.8 (8H, m, CH,), 2.39 (2H, t, CH2CO), 3.20 (2H, t, NCH2) . To a solution of 10 g (44.6 mmol) of 7-guanidinoheptanoic acid (HCl salt) in 56 ml of MeOH was added 0.5 ml of Dowex 50W (H+), and the mixture was refluxed for 3.5 hours. After cooling, the catalyst was removed by filtration and the solution was evaporated to dryness, giving methyl 7-guanidinoheptanoate (HCl salt) as a syrup. The methyl ester underwent ammonolysis without further purification when 35 ml of ammonium hydroxide was added. After being stirred overnight at room temp, the solution was evaporated and dissolved in H,O (10 ml). The solid, which was 7-guanidinoheptanoic acid, was removed by filtration and the remaining solution was passed through a column (160 ml) of CM-Sephadex C-25 (Na+). After being washed with 600 ml of H,O, the column was eluted with 0.5 M NaCl solution. Fractions positive for the Sakaguchi reaction were combined, evaporated, desalted with EtOH extraction, and chromatographed on a Sephadex LH-20 column as described in Section (A), giving 7.52 g (76%) of 7-guanidinoheptanamide (HCl salt): mp 127-130°C; IR (KBr) 3350, 3150, 2920, 1655, 1630, 1590, 1455, 1430, 1400, 1220, 1165, 1130 , 1065 cm-1; 1H NMR (CD3OD) 1.2' 1.9 (8H, m, CH,), 2.23 (2H, t, CH,CO), 3.20 (2H, t, NCH, ) A mixture of 7.50 g (33.7 mmol) of 7-guanidinoheptanamide (HCl salt), 8.97 g (30.7 mmol) of IIa, 4.05 g (30.7 mmol) of glutaric acid, and 2.0 g of 1120 was kept at 60°C for 8 hours. The reaction mixture was chromatographed and purified as described for compound 3 in Section (A), giving 6.08 g (39.3 %) of 18: IR (KBr) 3300, 3250, 3160, 2925, 2850, 1645, 1520, 1460, 1360, 1260, 1160, 1115, 1070 Spectral data of compounds 14, 15, 16, 23 and 25 were as follows.
I-Amino-l6-guanidino-1 I-hydroxy-4,9,12-triazahexadecane-10,13-dione (14) IR ( 1-Amino-l8-guanidino-1 l-hydroxy-4,9,12-triazaoctadecane-10,13-dione (16) IR (KBr) 3270, 2950, 1660, 1530, 1460, 1370, 1240, 1165, 1120 , 1080 cm-1; 1H NMR (CD,OD) 1.4-2.0 (10H, m, CH,), 2.0-2.5 (4H, m, CH2), 2.9-3.4 (10H, NCH2), 5.52 (1 H, s, 11-CH).
1-Amino-20-guanidino-11-hydroxy-4,9,12-triazaeicosane-10,13-dione (23) 1.4-2.4 IR ( 5, 17, 19, 20, 21, 22, 24 and 26) 1-Amino-l9-guanidino-l 1-methoxy-4,9,12-triazanonadecane-10,13-dione
A mixture of 27.5 g (55.3 mmol) of 18, 150 ml of MeOH, and 2.5 ml of 36 % HCl was stirred at room temp overnight. The reaction mixture was evaporated to dryness and dissolved in H,O (200 ml). The solution was adjusted to pH 5 with 0.5 N NaOH and chromatographed on CM-Sephadex C-25 (Na+) and Sephadex LH-20 as described for compound 3 in Section (A), giving 22.0 g (78 %) of 19. IR (KBr) 3420, 2950, 1650, 1520, 1460, 1360, 1190, 1160, 1090 cm-1 By a procedure similar to that described above for compound 19, compounds 5, 17, 20, 21, 22, 24 and 26 were prepared by replacing MeOH with the corresponding alcohol. Their spectral data were as follows.
1-Amino-l9-guanidino-11-methoxy-i 5-propionyloxy-4,9,12-triazanonadecane-10,13-dione (5) [a]D +2.2° (c 1, H,O); IR (KBr) 3400, 3180, 2940, 1720, 1660, 1530, 1460, 1200 , 1085 cm-1; 1H NMR (CD3OD) 1.10 (3H, t, CH3), 1.4-2.0 (10H, m, CH2), 2.2 (2H, m, 2-CH,), 2.34 (2H, q, COCH2), 2.63 (2H, d, (10H, NCH2), 3.38 (3H, s, OCH3), 5.20 (1H, m, 5.29, 5.30 (I H, s, s, I1-CH).
1-Amino-l8-guanidino-1 l-methoxy-4,9,12-triazaoctadecane-10,13-dione (17) IR ( KBr) 3420, 2940 KBr) 3420, , 1650 KBr) 3420, , 1520 KBr) 3420, , 1460 KBr) 3420, , 1355 KBr) 3420, , 1190 KBr) 3420, , 1160 KBr) 3420, , 1090 -l9-guanidino-11-ethoxy-4,9,12-triazanonadecane-10,13-dione (20) IR (KBr) 3400, 2930, 1655, 1520, 1460, 1360, 1160 , 1085 cm-1; 1H NMR (CD3OD) 1.23 (3H, t, CH3), 1.3-2.0 (12H, m, CH2), 2.0-2.5 (4H, m, CH2), 2.9'-3.4 (10H, NCH2), 3.64 (2H, q, OCH2), 5.42 (1H, s, 11-CH).
1-Amino
1-Amino-l9-guanidino-l l-(2'-hydroxy)ethoxy-4,9,12-triazanonadecane-10,13-dione (21) IR (KBr) 3370, 2930, 1655, 1520, 1455, 1355, 1165, 1110 , 1060 cm-1; 1H NMR (CD,OD) 1.2--2.0 (12H, m, CH2), 2.0-2.5 (4H, m, CH2), 2.9" 3.4 (10H, NCH2), 3.70 (4H, t, t, OCH2), 5.45 (1H, s, 11-CH).
1-Amino-l9-guanidino-11-benzyloxy-4,9,12-triazanonadecane-10,13-dione (22) IR (KBr) 3340, 2930, 1655, 1520, 1450, 1160, 1065, 1020, 740 , 695 cm-1; 1H NMR (CD3OD) 1.2 --2.0 (12H, m, CH,), 2.0 -2.5 (4H, m, CH2), 2.9 -3.4 (10H, NCH2), 4.64 (2H, s, OCH2), 5.51 (1 H, s, 7.32 (5H, s, C, H, ) .
I-Amino-20-guanidino-Il-methoxy-4,9,12-triazaeicosane-10,13-dione (24) IR (KBr) 3400, 2925 , 1650 , 1455 , 1355 , 1250 , 1190 , 1090 1H NMR (CD3OD) 1.2 2.0 (14H, m, CH2), 2.0-2.5 (4H, m, CH,), 2.9 3.4 (10H, NCH2), 3.37 (3H, s, OCH,), 5.28 (1H, s, 11-CH) . 1-Amino-21-guanidino-1 l-methoxy-4,9,12-triazauneicosane-10,13-dione (26) IR (KBr) 3400, 2930 , 1655 , 1360 , 1190 , 1090 -l8-guanidino-11,14-dihydroxy-4,9,12-triazaoctadecane-10,13-dione (28) To a solution of 2 g (11.0 mmol) of L-lysine in H,O (10 ml) were added 1.90 g (6.0 mmol) of Ba(OH), and 1.68 g (6.0 mmol) of S-methylisothiourea hemisulfate. The mixture was stirred at 80°C for 2 hours and brought to pH 6.5 with 2 N H2SO4. The resulting precipitate was removed by filtration and the filtrate was purified by chromatography on CM-Sephadex C-25 (Na+) and Dowex 50 W (H+), giving 1.48 g (72%) of (S)-6-guanidino-2-aminohexanoic acid: mp 220'-222°C; [a]D +13.6° (c 1, H2O).
To a solution of 970 mg (5.2 mmol) of (S)-6-guanidino-2-aminohexanoic acid in 35% acetic acid (68 ml) was added a solution of 1.28 g (18.6 mmol) of sodium nitrite in H,O (3 ml). The mixture was stirred at room temp for 4 hours and the resulting mixture was purified by chromatography on Dowex 50 W (H+), giving 674 mg (69%) of (S)-6-guanidino-2-hydroxyhexanoic acid: mp 242-246°C;
[a]D -0.2° (c 1, 1 N HCl).
Methylation and amidation of (S)-6-guanidino-2-hydroxyhexanoic acid as in the preparation of III in Section (B) gave 543 mg (78 %) of (S)- (14S)-1-Amino-l7-guanidino-11,14-dihydroxy-4,9,12-triazahexadecane-10. 13-dione (27) [a]D -10.5° (c 1, H2O); IR (KBr) 3360, 3180, 2950, 1660, 1525, 1515, 1460, 1115 , 1080 cm-1; 1H NMR (CD33OD) 1.52.0 (81-I. m, CH,), 2.12 (2H, 2-CH2), 2.9-3.5 (10H, NCH2), 4.10 (1H, t, 14-CH), 5.51 (IH, s, 11-CH).
1-Amino-l9-guanidino-11,14-dihydroxy-4,9,12-triazanonadec _ane-10,13-dione (29) A solution of 2.56 g (10 mmol) of 6-benzyloxycarbonylaminohexanoic acid and 1.78 g (11 mmol) of 1,1-carbonyldiimidazole in tetrahydrofuran (THF, 70 ml) was stirred for 20 minutes at room temp. To the solution, while being cooled at -15°C, was added 759 mg (20 mmol) of lithium aluminum hydride with THF (30 ml) for 30 minutes at the same temp, and the solution was acidified with 2 N HCl (5 ml) and evaporated in racuo. The resulting residue was extracted with CHCl., (120 ml), and the CHCl, layer was washed with saturated NaHCO3 solution and brine, dried over Na2SO4, and evaporated in racuo. The residue was chromatographed on silica gel (70 g) with elution by CHCl3, giving 1.51 g (59%) of 6-bcnzyloxycarbonylaminohexanal: 1H NMR (neat) 1.21.9 (6H, m, CH2), 2.42 (2H, t, 2-CH2), 3.18 (2H, q, 6-CH2), 4.85 (11-1, NH), 5.10 (2H, s, CH2), 7.32 (5H, s, C6H5), 9.75 (1H, t, CHO).
A mixture of 1.35 g (5.42 mmol) of 6-benzyioxycarbonylaminohexanal, 664 mg (13.55 mmol) of sodium cyanide and 36 % HCl (1.19 mmol) was stirred for 15 minutes. To this mixture were slowly added H2O (6 ml) and ether (6 ml), over a period of 1 hour, and it was stirred for another 1 hour. The reaction mixture was extracted with ether (10 ml x 3) and washed with brine (15 ml x 2). The ether portion was evaporated in vacuo, giving 1.34 g (89.6%) of the desired cyanohydrin, 6-benzyloxycarbonylamino-l-hydroxyhexanecarbonitrile:
'II. NMR (CD3OD) 1.2-1.9 (8H, m, CH2), 3.12 (2H, m, NCH2), 4.44 (1H, t, CH), 5.07 (2H, s, CH2), 7.30 (5H, s, C6H5).
The cyanohydrin (1.18 mg, 4.27 mol) in MeOH (20 ml) and I N HCl (5 ml) was hydrogenated with 10%, palladium on charcoal under a stream of hydrogen at atmospheric pressure for 2.5 hours at room temp. The catalyst was removed by filtration and the filtrate was evaporated. The residue was dissolved in H2O (50 ml), and the solution was washed with EtOAc (50 ml). The aqueous layer was evaporated to dryness, giving 794 mg of crude 6-amino-l-hydroxyhexanecarbonitrile.
The residue obtained above was dissolved in 36 % HCl (5 ml) and stirred overnight. The reaction mixture was diluted with H2O (30 ml), brought to pH 6.5 with 0.5 N NaOH, and purified by chromatography on CM-Sephadex C-25 and Sephadex LH-20 as described in Section (A), giving 277.8 mg of 7-amino-2-hydroxyheptanamide (HCl salt): 1H NMR (DO) 1.3-2.0 (8H, m, CH2), 2.98 (2H, t, NCH2), 4.04 (1 H, t, .
Conversion of the generated amino group into a guanidino group as for 18 in Section (B), gave 199.5 mg (59.3 %) of 7-guanidino-2-hydroxyheptanamide (HCl salt): 1H NMR (D,O) 1.3-2.0 (8H, m, CM), 3.2 (2H, t, NCH,), 4.03 (IH, t, 2-CH).
Acid-catalyzed condensation of 200 mg (0.84 mmol) of 7-guanidino-2-hydroxyheptanamide with 295 mg (1.01 mmol) of II, as described in Sections (A) and (B), gave 79 mg (18%) of 29: IR (KBr) 3360, 2950, 1660, 1525, 1460, 1110cm-1; 1H NMR (CD,OD) 1.2 2.4 (14H, m, CH2), 2.9 3.4 (10H, NCH 2), 4.03 (1 H, m, 14-CH), 5.50 (1 H, s, .
(E) Preparation of 15-Epimeric-spergualin Analogues (Compounds 30, 31 and 32) 9, A solution of 2.65 g (10 mmol) of 6-benzyloxycarbonylaminohexanoic acid and 1.62 g (10 mmol) 14-CH).
1-Amino-21-guanidino-11
-hydroxy-4,9,12-triaza-l4-uneicosene-10,13-dione (35) IR (KBr) 3400, 2940 , 2850 , 1530 , 1360 , 1225 , 1115 , 1080 
